MedTrace Logo

The RESHAPE-HF1-FU Study

NCT02444286 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-01-05

No results posted yet for this study

Summary

To evaluate the safety and efficiency of the MitraClip system in the treatment of patients with clinically significant mitral regurgitation with New York Heart Association (NYHA) Functional Class II to IV chronic heart failure.

Conditions

  • Mitral Valve Insufficiency

Sponsors & Collaborators

  • University Medical Center Goettingen

    collaborator OTHER

  • Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02444286 on ClinicalTrials.gov